10-Q: Select Medical Holdings Reports Q1 2025 Results: Revenue Up, Earnings Down Due to Concentra Spin-Off

Select Medical Holdings saw a revenue increase in Q1 2025, but net income decreased due to the spin-off of Concentra.

Summary

• Select Medical Holdings Corporation reported its Q1 2025 financial results.
• Revenue increased to $1,353.2 million, up from $1,321.2 million in Q1 2024.
• Net income decreased to $74.7 million, compared to $117.2 million in the same period last year.
• The decrease in net income is primarily attributed to the spin-off of Concentra.
• Adjusted EBITDA was $151.4 million, with a margin of 11.2%, compared to $165.8 million and a margin of 12.5% in Q1 2024.
• Earnings per share from continuing operations were $0.44, down from $0.75 in the prior year which included discontinued operations.
• The company's critical illness recovery hospital segment saw a revenue decrease, while the rehabilitation hospital segment experienced growth.
• The outpatient rehabilitation segment also saw a slight increase in revenue.
• The company repurchased 649,804 shares of its common stock at a cost of approximately $11.4 million during the quarter.
• A cash dividend of $0.0625 per share was declared on April 30, 2025.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While revenue increased, net income decreased due to the Concentra spin-off. The company is facing cost pressures and regulatory challenges, but it is also taking steps to manage its capital and return value to shareholders.

Positives

• Overall revenue increased by 2.4% to $1,353.2 million.
• The rehabilitation hospital segment experienced a significant revenue increase of 15.7%.
• The outpatient rehabilitation segment also saw a revenue increase of 1.4%.
• The company continues to repurchase shares, indicating confidence in its future prospects.
• A dividend was declared, returning value to shareholders.

Negatives

• Net income decreased significantly due to the spin-off of Concentra.
• Adjusted EBITDA and its margin decreased compared to the same period last year.
• The critical illness recovery hospital segment experienced a revenue decrease of 2.9%.

Risks

• Changes in government reimbursement policies could reduce revenue and profitability.
• Adverse economic conditions, including inflation, could increase labor and other costs.
• Shortages of qualified healthcare professionals could limit the ability to staff facilities.
• Failure to maintain Medicare certifications could cause revenue and profitability to decline.
• Government investigations or assertions of regulatory violations could result in sanctions or reputational harm.
• Acquisitions or joint ventures may prove difficult or unsuccessful.
• Private third-party payors may adopt payment policies that limit future revenue and profitability.
• Competition may limit growth and decrease revenue and profitability.
• Loss of key management team members could disrupt operations.
• Security breaches of information technology systems may subject the company to legal and reputational harm.
• Changes to United States tariff and import/export regulations and macroeconomic conditions may have a negative effect on the business, financial condition and results of operations.

Future Outlook

The company believes its internally generated cash flows and borrowing capacity will allow it to finance operations in the short and long term and may pursue opportunities to develop new joint venture relationships and open new outpatient rehabilitation clinics and may grow through opportunistic acquisitions.

Industry Context

The healthcare industry is facing increasing regulatory scrutiny and reimbursement challenges, as well as rising labor costs and potential supply chain disruptions. Select Medical's performance reflects these industry-wide trends, with revenue growth offset by cost pressures and regulatory changes.

Comparison to Industry Standards

• Select Medical operates in the post-acute care sector, which includes long-term acute care hospitals (LTCHs), inpatient rehabilitation facilities (IRFs), and outpatient rehabilitation clinics.
• Competitors in the LTCH space include Kindred Healthcare (now part of LifePoint Health) and Vibra Healthcare.
• In the IRF space, competitors include Encompass Health and Kindred Healthcare.
• For outpatient rehabilitation, Select Medical competes with companies like ATI Physical Therapy and U.S. Physical Therapy.
• Select Medical's Adjusted EBITDA margin of 11.2% is within the typical range for companies in this sector, but it is lower than some of its peers, such as Encompass Health, which often reports higher margins.
• The company's revenue growth of 2.4% is moderate compared to some of the faster-growing companies in the outpatient rehabilitation space.

Legal Proceedings

• The company is a party to various legal actions, proceedings, and claims, and regulatory and other governmental audits and investigations in the ordinary course of its business.
• The Department of Justice, Centers for Medicare & Medicaid Services (CMS), or other federal and state enforcement and regulatory agencies may conduct additional investigations related to the Companys businesses in the future that may, either individually or in the aggregate, have a material adverse effect on the Companys business, financial position, results of operations, and liquidity.
• On August 24, 2020, the Company and Select Specialty Hospital Oklahoma City, Inc. (SSHOklahoma City) received civil investigative demands (CIDs) from the U.S. Attorneys Office for the Western District of Oklahoma seeking responses to interrogatories and the production of various documents principally relating to the documentation, billing and reviews of medical services furnished to patients at SSH-Oklahoma City.
• On October 7, 2021, the Company received a letter from a Trial Attorney at the U.S. Department of Justice, Civil Division, Commercial Litigation Branch, Fraud Section (DOJ) stating that the DOJ, in conjunction with the U.S. Department of Health and Human Services (HHS), is investigating the Company in connection with potential violations of the False Claims Act, 31 U.S.C. 3729, et seq.

Stakeholder Impact

• Shareholders will receive a dividend of $0.0625 per share.
• Employees may be affected by cost-cutting measures or changes in staffing levels.
• Patients may be affected by changes in service offerings or quality of care.
• Suppliers may be affected by changes in purchasing patterns or pricing negotiations.
• Creditors may be affected by changes in the company's debt levels or credit ratings.

Next Steps

• The company may pursue opportunities to develop new joint venture relationships.
• The company intends to open new outpatient rehabilitation clinics.
• The company may grow through opportunistic acquisitions.
• The company may from time to time seek to retire or purchase outstanding debt.
• The dividend will be payable on or about May 29, 2025 to stockholders of record as of the close of business on May 15, 2025.

Key Dates

Keywords

financial results, revenue, net income, Adjusted EBITDA, critical illness recovery hospital, rehabilitation hospital, outpatient rehabilitation, Medicare, dividends, stock repurchase, Concentra, spin-off